A Clinical Study of TJ004309 With Atezolizumab (TECENTRIQ®) in Patients With Ovarian Cancer and Selected Solid Tumors

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York

Medical Oncology Hematology Consultants, PA, Newark

Maryland Oncology Hematology, Rockville

Virginia Cancer Specialists, Fairfax

Duke Cancer Center, Durham

Tri County Hematology and Oncology Associates, Massillon

Illinois Cancer Specialists, Arlington Heights

Women's Cancer Care, Covington

Texas Oncology - Longview Cancer Center, Tyler

Texas Oncology - Arlington North, Arlington

Texas Oncology - Bedford, Bedford

Texas Oncology - Forth Worth Cancer Center, Fort Worth

Texas Oncology - The Woodlands, Gynecologic Oncology, The Woodlands

Texas Oncology - Austin Central, Austin

Arizona Oncology Associates, Tucson

Innovative Clinical Research Institute, Whittier

Northwest Cancer Specialists, Vancouver